期刊文献+

逆向调强放射治疗肺癌患者发生放射性肺炎相关因素分析 被引量:13

Analysis of factors of radiation pneumonitis in patients with lung cancer treated with intensity-modulated radiation therapy
下载PDF
导出
摘要 目的分析逆向调强放射治疗(IMRT)肺癌患者的临床资料和放疗计划的物理参数,评估临床因素、物理参数与放射性肺炎发生的关系。方法回顾性分析63例实施IMRT的肺癌患者资料,比较发生放射性肺炎和未发生放射性肺炎患者治疗计划的剂量体积直方图及临床影响因素。分析病理、肿瘤位置、同步化疗、照射剂量和放疗方式等临床数据,剂量学参数包括肺V5、V10、V15、V20、V25、V30、V35、V40和平均剂量等物理参数。分析上述因素对放射性肺炎发生率的影响。结果发生2级以上放射性肺炎19例。单因素分析显示照射总剂量和病理类型为小细胞肺癌与放射性肺炎相关。多因素分析显示仅V5与放射性肺炎相关。结论实施肺癌IMRT治疗时,需考虑病理类型及严格限制两肺V5,对于敏感的肺组织,低剂量亦可产生损伤。 Objective To evaluate the correlation of clinical factors and radiation therapy factors with incidence of radiation pneumonitis in patients with lung cancer treated with intensity-modulated radiation therapy ( IMRT). Methods The medical records of 63 patients with lung cancer treated with IMRT were retrospectively analysed. The dose volume histogram of treatment program and clinical influencing factors were compared between patients with radiation pneumonitis and those without radiation pneumonitis. The clinical parameters were observed, which included pathology, tumor location, concurrent chemotherapy, dose and pattern of radiation, and the dosimetric factors included Vs, Vlo, Vt5, V20, V25, V30, V35, V40 and mean lung dose. The effect of above factors on the incidence of radiation pneumonitis was analysed. Results Among the 63 patients, 19 experienced radiation pneumonitis. Univariate analysis revealed that total dose and small cell lung cancer as pathological type were significantly associated with the incidence of radiation pneumonitis. Multivariate analysis indicated that only V5 was the risk factor of radiation pneumonitis. Conclusion Pathological type and V5 value should be considered in the IMRT for lung cancer, and low dose may also cause injury to sensitive lung tissues.
出处 《上海交通大学学报(医学版)》 CAS CSCD 北大核心 2013年第4期485-488,501,共5页 Journal of Shanghai Jiao tong University:Medical Science
关键词 肺癌 调强放射治疗 放射性肺炎 剂量体积直方图 临床因素 lung cancer intensity-modulated radiation therapy radiation pneumonitis dose volume histograms clinicalfactors
  • 相关文献

参考文献18

  • 1Peng G, Wang T, Yang KY, et al. A prospective, randomized study comparing outcomes and toxicities of intensity-modulated radiotherapy vs. conventional two-dimensional radiotherapy for the treatment of nasopharyngeal carcinoma[ J ]. Radiother Oncol, 2012, 104 ( 3 ) : 286 - 293.
  • 2Barriger RB, Fakiris AJ, Hanna N, et al. Dose-volume analysis of radiation pneumonitis in non-small-cell lung cancer patients treated with concurrent cisplatinum and etoposide with or without consolida- tion docetaxel[J]. Int J Radiat Oncol Biol Phys, 2010, 78 (5): 1381 - 1386.
  • 3Werner-Wasik M, Paulus R, Curran WJ Jr, et al. Acute esophagitis and late lung toxicity in concurrent chemoradiotherapy trials in patients with locally advanced non-small-cell lung cancer: analysis of the radiation therapy oncology group (RTOG) database[J]. Clin Lung Cancer, 2011, 12(4) : 245 -251.
  • 4Phernambucq EC, Spoelstra FO, Verbakel WF, et al. Outcomes of concurrent chemoradiotherapy in patients with stage III non-small- cell lung cancer and significant comorbidity[J]. Ann Oncol, 2011, 22(1): 132-138.
  • 5RTOG Acute Radiation Mobidity Scoring Criteria [ S ]. www. rtog. org/Research Associates/Adverse Event Reporting. aspx.
  • 6Bezjak A, Rumble RB, Rodrigues G, et al. Intensity-modulated radiotherapy in the treatment of lung cancer[ J]. Clin Oncol (R Coll Radiol), 2012, 24(7) : 508 -520.
  • 7Jiang ZQ, Yang K, Komaki R,et al. Long-term clinical outcome of intensity-modulated radiotherapy for inoperable non-small cell lung cancer: the MD Anderson experience [ J ]. Int J Radiat Oncol Biol Phys, 2012, 83(1): 332-339.
  • 8Govaert SL, Troost EG, Schuurbiers OC, et al. Treatment outcome and toxicity of intensity-modulated (chemo) radiotherapy in stage III non-small cell lung cancer patients [J]. Radiat Oncol, 2012, 7: 150.
  • 9Allen AM, Czerminska M, Janne PA, et al. Fatal pneumonitis asso- ciated with intensity-modulated radiation therapy for mesothelioma [J]. Int J Radiat Oncol Biol Phys, 2006, 65(3) : 640 -645.
  • 10Graham MY, Purdy JA, Emami B, et al. Clinical dose-volume his- togram analysis for pneumonitis after 3D treatment for non-small cell lung cancer (NSCLC) [ J]. Int J Radiat Oncol Biol Phys, 1999, 45 (2) : 323 -329.

同被引文献102

引证文献13

二级引证文献43

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部